Arterial hypertension in liver transplant recipients

Transplantation Proceedings

Volumn 43, Issue 8, 2011, Pages 3029-3034

  Hryniewiecka, E ^a   Zegarska, J ^a   Paczek L ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BASILIXIMAB; CYCLOSPORIN; PREDNISONE; TACROLIMUS;

ADULT; ANTIHYPERTENSIVE THERAPY; BLOOD CHEMISTRY; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONFERENCE PAPER; DIASTOLIC BLOOD PRESSURE; DRUG BLOOD LEVEL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRAFT RECIPIENT; HEART RATE; HEPATITIS B; HEPATITIS C; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; NEPHROTOXICITY; POSTOPERATIVE PERIOD; PRESCRIPTION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; FEMALE; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TACROLIMUS; TIME FACTORS;

EID: 80054773455     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.07.011     Document Type: Conference Paper

References (43)

1. O. Ciccarelli, B. Kaczmarek, and F. Roggen Long-term medical complications and quality of life in adult recipients surviving 10 years or more after liver transplantation Acta Gastroenterol Belg 68 2005 323
2. T.R. Fouad, W.M. Abdel-Razek, and K.W. Burak Prediction of cardiac complications after liver transplantation Transplantation 87 2009 763
3. V.J. Canzanello, L. Schwartz, and S.J. Taler Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506) Liver Transpl Surg 3 1997 1
4. C. Fernandez-Miranda, M. Sanz, and A. dela Calle Cardiovascular risk factors in 116 patients 5 years or more after liver transplantation Transpl Int 15 2002 556
5. A.B. Jain, R. Kashyao, and J. Rakela Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events Liver Transpl Surg 5 1999 144
6. J.M. Rabkin, H.R. Rosen, and C.L. Corleess Tacrolimus is associated with a lower incidence of cardiovascular complication in liver transplant recipients Transplant Proc 34 2002 1557
7. D.A.J. Neal, M.J. Brown, and I.B. Wilkinson Mechanisms of hypertension after liver transplantation Transplantation 79 2005 935
8. S.C. Textor De-novo hypertension after liver transplantation Hypertension 22 1993 257
9. V.J. Canzanello, S.C. Textor, and S.J. Taler Renal sodium handling with cyclosporine A and FK506 after orthotopic liver transplantation J Am Soc Nephrol 5 1995 1910
10. D.L. Ciresi, M.A. Lloyd, and S.M. Sandberg The sodium retaining effects of cyclosporine Kidney Int 41 1992 1599
11. J.M. Hansen, N. Fogh-Andersen, and N.J. Christensen Cyclosporine-induced hypertension and decline in renal function in healthy volunteers J Hypertens 15 1997 319
12. N.D.C. Sturrock, C.C. Lang, and A.D. Struthers Cyclosporin-induced hypertension precedes renal dysfunction and sodium retention in man J Hypertens 11 1993 1209
13. J.P. Bantle, M.S. Paller, and R.J. Boudreau Long-term effects of cyclosporine on renal function in organ transplant recipients J Lab Clin Med 115 1990 233
14. D.B. Lee Cyclosporine and the rennin-angiotensin axis Kidney Int 52 1997 248
15. V.J. Canzanello, S.C. Textor, and S.J. Taler Late hypertension after liver transplantation: a comparison of cyclosporine and tacrolimus (FK506) Liver Transpl Surg 4 1998 328
16. S.C. Textor, R. Wiesner, and D.J. Wilson Systemic and renal hemodynamic differences between FK506 and cyclosporine A in liver transplant recipients Transplantation 55 1993 1332
17. M.R. Lucey, M.F. Abdelmalek, and R. Gagliardi A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status Am J Transplant 5 2005 1111
18. A. Rossetto, D. Bitetto, and V. Bresadola Cardiovascular risk factors and immunosuppressive regimen after liver transplantation Transplant Proc 42 2010 2576
19. A.O. Ojo, P.J. Held, and F.K. Port Chronic renal failure after transplantation of a nonrenal organ N Engl J Med 349 2003 931
20. N.C. Fisher, P.G. Nightingale, and B.K. Gunson Chronic renal failure following liver transplantation Transplantation 66 1998 59
21. P.S. Randhawa, and R. Shapiro Chronic renal failure after liver transplantation Am J Transplant 5 2005 967
22. T.G. Pickering, J.E. Hall, and L.J. Appel Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research Hypertension 45 2005 142
23. The Task Force for management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology 2007 Guidelines for the management of arterial hypertension Eur Heart J 28 2007 1462
24. A.S. Levey, L.A. Stevens, and C.H. Schmid A new equation to estimate glomerular filtration rate Ann Int Med 150 2009 604
25. S.J. Taler, S.C. Textor, and V.J. Canzanello Cyclosporin-induced hypertension: Incidence, pathogenesis and management Drug Saf 20 1999 437
26. R. Cifkova, J. Pit'ha, and P. Trunecka Blood pressure, endothelial function and circulating endothelin concentrations in liver trans plant recipients J Hypertens 19 2001 1359
27. K. Boudjema, C. Camus, and F. Saliba Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study Am J Transplant 11 2011 965
28. J. Devlin, R. Wiliams, and P. Neuhaus Renal complications and development of hypertension in the European study of FK506 and cyclosporine in primary liver transplant recipients Transpl Int 7 suppl 1 1994 S522
29. S. Todo, J.J. Fung, and A. Tzakis One hundred ten consecutive primary orthotopic liver transplants under FK506 in adults Transplant Proc 23 1991 1397
30. E. Otero-Anton, E. Padin, and A. Tome Utility of ambulatory blood pressure monitoring for diagnosis of hypertension in liver allograft recipients Transplant Proc 35 2003 718 (Pubitemid 36338130)
31. R.A. Reeves, A.P. Shapiro, and M.E. Thompson Loss of nocturnal decline in blood pressure after cardiac transplantation Circulation 73 1986 401
32. M.E. Del Compare, D. D'Agostino, and J.R. Ferraris Twenty-four-hour ambulatory blood pressure profiles in liver transplant recipients Pediatr Transplant 8 2004 496
33. S.L. Taler, S.C. Textor, and V.J. Canzanello Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapy Am J Hypertens 8 1995 598
34. P. van de Borne, M. Leeman, and G. Primo Reappearance of a normal circadian rhythm of blood pressure after cardiac transplantation Am J Cardiol 1992 794
35. R.G. Luke Mechanism of cyclosporine-induced hypertension Am J Hypertens 4 1991 468
36. P. van de Borne, M. Gelin, and J. Van de Stadt Circadian rhythms of blood pressure after liver transplantation Hypertension 21 1993 398
37. R. Dikow, M. Degenhard, and T. Kraus Blood pressure profile and treatment quality in liver allograft recipientsbenefit of tacrolimus versus cyclosporine Transplant Proc 36 2004 1512
38. S.J. Taler, S.C. Textor, and V.J. Canzanello Renal function predicts hypertension severity and circadian BP patterns five years after liver transplantation [abstract] J Am Soc Nephrol 9 1998 717A
39. R.P. Kershner, and W.E. Fitzsimmons Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation Transplantation 62 1996 920
40. T.A. Gonwa, M.L. Mai, and L.B. Melton End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy Transplantation 72 2001 1934
41. A. Jain, J. Reyes, and E. Kashyap What we have learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients Ann Surg 230 1999 441
42. US Multicenter FK506 Liver Study Group A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation N Engl J Med 331 1994 1110
43. K.P. Platz, A.R. Mueller, and G. Blumhardt Nephrotoxicity following orthotopic liver transplantation: a comparison between cyclosporine and FK506 Transplantation 58 1994 170